Clinical Trial of Recombinant Adenovirus Type 5 AIDS Vaccine

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This is a randomized, double-blind placebo-controlled dose-escalation clinical trial to evaluate the safety and the immunogenicity of Adenoviral vector 5 HIV-1 vaccines in subjects receiving stable highly active antiretroviral therapy(HAART) .
Epistemonikos ID: 97d201877fa5739dbedf439b8e02f89aea726f9f
First added on: May 13, 2024